Search the Newsreel

BridgeBio Pharma Announces Launch of Secondary Offering of Common Stock on Behalf of an Existing Shareholder

BridgeBio Pharma, Inc. (Nasdaq: BBIO) has announced a secondary public offering of 5,000,000 shares of its common stock by KKR Genetic Disorder L.P., an existing shareholder. BridgeBio itself is not selling any shares and will not receive any proceeds from this offering. William Blair, …

KKR Proposes Sale of 5 Million BridgeBio Pharma Shares in Offering

BridgeBio Pharma (BBIO) announced a secondary public offering of 5,000,000 shares of its common stock, to be sold by existing shareholder KKR Genetic Disorder L.P. BridgeBio will not sell any shares in this transaction and will not receive any proceeds. The offering is subject …

Bridgeline Digital Q3 Results: Core Revenue Up 13%, Loss Narrows

Bridgeline Digital (NASDAQ: BLIN) reported Q3 FY26 results, missing analyst expectations with a loss of $(0.04) per share against an estimated $(0.01) and revenue of $3.922 million against a $4.700 million target. Despite the overall revenue miss, core product revenue, primarily driven by AI-powered …

U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse

Bristol Myers Squibb announced that the U.S. FDA has granted accelerated approval for ZENBEXUS™ (iberdomide) in combination with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd) for adult patients with multiple myeloma who have received at least one prior line of therapy. This approval, based on …

Earnings call transcript: Bridgeline Digital Q3 2026 revenue miss weighs on shares

Image source: The Motley Fool. DATE Thursday, Aug. 13, 2026, at 4:30 p.m. ET CALL PARTICIPANTS Chief Financial Officer-Thomas Windhausen President and Chief Executive Officer-Ari Kahn Full Conference Call Transcript Operator: Good afternoon, and welcome to Bridgeline Digital's Third Quarter 2026 Earnings Call. Please …

Bridgeline Digital (BLIN) Stock Falls on Q3 2026 Earnings

Bridgeline Digital (BLIN) reported Q3 2026 revenue of $3.9 million, missing Wall Street expectations of $4.8 million, and a net loss of $468,000. Following the announcement, the stock fell by 6.19%. Insider trading data shows recent purchases by company executives, while institutional investors largely …

Stock Market Today, Aug. 13: Cellebrite Shares Plummet 29% After Missing Earnings, Cutting 2026 Revenue Guidance

Bridgeline Digital Q3 EPS misses estimates, sales miss $4.7M target

NovaBridge webcast to cover oncology and ophthalmology programs

NovaBridge Biosciences (Nasdaq: NBP) announced it will host a webcast on Thursday, August 20, 2026, at 9:00 AM ET / 9:00 PM China Standard Time to discuss recent corporate progress and financial results for the first half ended June 30, 2026. The company is …

NovaBridge to Report First Half 2026 Financial Results and Provide a Corporate Update on Thursday, August 20, 2026

NovaBridge Biosciences announced it will hold a webcast on Thursday, August 20, 2026, to discuss its first half 2026 financial results and corporate progress. The company, a global biotechnology firm focused on oncology and ophthalmology, will host the webcast at 9:00 AM ET/9:00 PM …

Should BrightSpring Health Services (BTSG) Be Revalued As Earnings And Guidance Shift?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. BrightSpring Health Services (BTSG) was in focus after releasing second quarter 2026 results on July 31, alongside updated full year revenue guidance that …

Bridgeline Digital, Inc. 2026: Revenue $3.92M, EPS ($0.04) — 10-Q Summary

Bridgeline Digital, Inc. reported its 2026 quarterly results, showing a 2% revenue increase to $3.92M and a narrowed net loss of ($468K), improving EPS to ($0.04). Subscription revenue, particularly from HawkSearch, was the main growth driver, offsetting declines in legacy products. The company also …

Bridgeline Digital (BLIN) narrows loss on $11.8M revenue and low debt

Bridgeline Digital (BLIN) reported total net revenue of $11.8 million for the nine months ended June 30, 2026, a modest increase from the prior year. The company narrowed its nine-month net loss to $1.0 million, compared to $2.2 million a year earlier, with Adjusted …

Brinker International (NYSE:EAT) Price Target Raised to $282.00 at Citigroup

Citigroup has raised its price target for Brinker International (NYSE:EAT) to $282.00 from $227.00, reiterating a "buy" rating and suggesting a 17.74% upside. This adjustment follows Brinker's strong quarterly revenue which beat estimates and exceeded fiscal 2027 guidance, despite a slight miss on quarterly …

Deutsche Pfandbriefbank Aktie: 249-Millionen-Verlust überwunden

US FDA approves Bristol Myers' blood cancer treatment

The U.S. FDA has approved Bristol Myers Squibb's combination treatment, iberdomide, for patients with a rare form of blood cancer called multiple myeloma. This treatment is intended for patients whose illness has relapsed or not responded to other therapies. Iberdomide works by targeting the …

CNQ or Enbridge? Here’s the Better Dividend Stock Right Now

Oxbridge Re Reports Solid Q2 2026 Results and Launches AI GridWorks to Develop and Own AI Data Centers

Oxbridge Re Holdings Limited announced solid Q2 2026 results, reporting net income of $176,000 and a significant increase in restricted cash. The company is strategically expanding into AI infrastructure with the launch of AI GridWorks, which will develop and operate AI data centers, complementing …

Oxbridge Re's AI unit brings 2.9 GW data-center experience

Oxbridge Re (NASDAQ: OXBR) reported a return to profitability in Q2 2026, with a net income of $176,000, and significantly increased its restricted cash. The company also launched AI GridWorks, a new subsidiary focused on developing, owning, and operating AI data centers, leveraging a …

Oxbridge Re (OXBR) posts H1 2026 profit as tokenized reinsurance expands

Oxbridge Re Holdings Limited (OXBR) reported a return to profitability for the first half of 2026, with a net income of $198,000, a significant improvement from a $2.0 million loss in the prior-year period. This turnaround was largely driven by management fees from its …

Cellebrite (CLBT) boosts H1 2026 revenue 17% while net income falls sharply

China Everbright Subsidiary Ying Li Narrows Loss on Lower Revenue and FX Gain

Kayne Anderson Rudnick (BFAM) discloses 5.5% Bright Horizons stake in 13G/A

Kayne Anderson Rudnick Investment Management, LLC has filed an amended Schedule 13G, disclosing a beneficial ownership of 5.5% in Bright Horizons Family Solutions Inc. This stake amounts to 2,879,927 shares of common stock as of June 30, 2026. The filing details the firm's sole …

Pharmacy giant Bristol Myers Squibb to build $2.3B Houston factory

Bristol Myers Squibb has chosen Houston, Texas, as the location for its new state-of-the-art manufacturing facility. This 60,000-square-foot site represents a $2.3 billion investment and is projected to create 500 skilled jobs in Generation Park. Construction is set to begin next year, with the …

British American Tobacco’s Job Cuts Draw Investor Buzz – Certain Roles To Be Outsourced To Partners In AI Adoption Push

Cellebrite Q2: This 33% Selloff Looks Like An Overreaction (NASDAQ:CLBT)

Cellebrite DI Ltd. (CLBT) experienced a significant 33% stock drop post-earnings, which the author believes is an overreaction. Despite missing Q2 guidance for ARR and revenue growth, and facing management transition and slower Inseyets conversions, the company maintains strong core products, high retention, and …

Cellebrite DI Releases Q2 2026 Financial Results

Cellebrite DI Ltd. reported mixed Q2 2026 financial results, with earnings per share meeting expectations at $0.11, while revenue of $131.1M slightly missed the $131.9M estimate. Despite the revenue miss, the company showed strong year-over-year growth, with total revenue up 16.0% and subscription services …

Form 8K OXBRIDGE RE HOLDINGS LIMITED For: 13 August By Investing.com

This article announces the filing of a Form 8K by OXBRIDGE RE HOLDINGS LIMITED for August 13. It notes the stock symbol OXBR and its recent price performance. The content is primarily a brief announcement with financial market context from Investing.com.

Seabridge Gold Files Second Quarter 2026 Report to Shareholders and Its Financial Statements and MD&A

Seabridge Gold announced the filing of its Second Quarter 2026 Report to Shareholders, Interim Financial Statements, and Management's Discussion and Analysis. The company reported a significant increase in net income to $117.5 million, largely due to gains from the Courageous Lake project distribution, and …

Kolibri Global Energy (NASDAQ:KGEI) Releases Earnings Results, Beats Estimates By $0.02 EPS

Kolibri Global Energy (NASDAQ:KGEI) announced strong second-quarter results, beating EPS estimates by $0.02 with a reported $0.23 EPS. The company achieved record revenue of $22.5 million and more than doubled its adjusted EBITDA to $16.4 million, driven by a 46% increase in production. Despite …

Appeals court revived a $6.7 billion lawsuit against Bristol Myers Squibb over delayed drug approvals

A federal appeals court has reinstated a $6.7 billion lawsuit against Bristol Myers Squibb, brought by UMB Bank on behalf of former Celgene shareholders. The suit alleges Bristol Myers deliberately delayed FDA approvals for three drugs, including the cancer therapy Breyanzi, to avoid payouts …

Brightstar Lottery (BRSL) Returned To Profit And Reaffirmed Guidance, Is It Still 32% Below Fair Value?

Earnings call transcript: Kolibri Global Energy posts record Q2 2026 revenue

Kolibri Global Energy reported record second-quarter 2026 revenue of $22.5 million, marking a 109% increase year-over-year, surpassing Wall Street estimates. Despite an EPS miss ($0.23 actual vs. $0.25 forecast), the company's stock rose 8.3% due to strong production, higher cash flow, and improved borrowing …

Enbridge Inc To Go Ex-Dividend On August 14th, 2026 With 0.97 CAD Dividend Per Share

Enbridge Inc. (TSX:ENB) has announced that it will go ex-dividend on August 14th, 2026. The company will pay a dividend of 0.97 CAD per share. This information is crucial for investors tracking dividend payouts.

Earnings call transcript: Bridgemarq beats Q2 2026 forecasts as stock rises

KGEI SEC Filings - Kolibri Global Energy Inc. 10-K, 10-Q, 8-K Forms

This page provides a comprehensive resource for Kolibri Global Energy Inc. (KGEI) SEC filings, including annual reports (10-K), quarterly reports (10-Q), material event reports (8-K), and insider trading forms (Form 4). It highlights recent Form 6-K filings detailing operational updates, financial results, and administrative …